OTCPK:MEDVF - Post by User
Comment by
Knowsitallon Nov 26, 2021 8:11am
109 Views
Post# 34167903
RE:RE:RE:MEDV is Creating value. FACT
RE:RE:RE:MEDV is Creating value. FACT GeneralWolfe wrote: NO, not the case at all. You are lying again... lolll, but nice try. Again, just facts. Some of the MEDV highlights from the zoom call. -Share Consolidation Passed - R/S was addressed and is “only” if needed to uplist but is not a priority they feel they can hit targets based on increasing and projected revenue going into 2022 -They are on pace for their projected revenue of 60M for 2021 (*From invester deck, looking at Q3 we could very well pass 60 million) -Spoke on Q4: "We anticipate to be just as good if not significantly better than Q3, trend it going in the right direction. Maybe a dip in November, fluctuation of business (10-15% dip from absolute peak)." *Q3 Revenue was $25.3 Million -Spoke to their software ,Govt asking for even more testing, different tests coming at locations, influenza and other tests, Focusing on expanding platforms with AI , Cholesterol and diabetes tech, prescriptions. -States MEDV is grossly undervalued, Says to deal with shorts by producing revenue results and increasing them.
I like you NAME
GeneralWolfe ..Tell us more about it . The origin the reason ,the history behind it. FACTS vs THEORY VS wishfull thinking VS BS ??????